Thursday, Apr 25 2024 | Time 17:40 Hrs(IST)
image
Business EconomyPosted at: Dec 12 2019 10:14PM


Drug Manufacturers Eye Analytical Instrumentation to Reduce Operating Costs

Emerging regions such as Asia-Pacific and Latin America to grow rapidly by 2025, finds Frost & Sullivan
SANTA CLARA, California, Dec. 12, 2019 /PRNewswire/ -- The total analytical instrumentation market in pharmaceuticals, biopharmaceuticals, and nutraceuticals generated revenues of $3.05 billion in 2018 and is expected to grow at a CAGR of 7.0% to touch $4.91 billion in 2025. Pharmaceuticals were the largest segment in 2018, with a share of 63.4%, while biopharmaceuticals and nutraceuticals held 20.7% and 15.9%, respectively.Biological drugs are expected to capture 52% of the top 100 products sales by 2022.
"There is high pressure on drug manufacturers to lower prices. Hence, they will have to create a flexible pricing strategy to maximize their profits and negotiate with payers," said Janani Balasundar, Research Analyst forMeasurement & Instrumentation at Frost & Sullivan. "Process analyzers that can be plugged in as part of the manufacturing process will help reduce operating costs for manufacturers."
Frost & Sullivan's recent analysis, Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025, analyzes the products and services offered. It studies the key applications of drug discovery and development testing, biopharmaceutical analytical testing, quality control testing, cancer research, and process analytical technology analysis. It covers the regions of North America, Europe, Asia-Pacific, and Rest-of-the-World (ROW).
For further information on this analysis, please visit: http://frost.ly/3vy
"Developing countries in Asia-Pacific, including Vietnam, China, and Sri Lanka, are expected to experience strong growth," noted Balasundar. "The Latin American pharmaceuticals market also is expanding significantly and will continue doing so throughout the forecast period. North America and Europe are strong focus regions for biosimilars; In the biosimilars segment, Europe held the highest share of 47.7% in 2018, and North America will achieve a CAGR of 32.7% in the forecast period."
Furthermore, there is likely to be high demand for mass spectrometer for characterization analysis in biosimilar analysis. Analytical equipment manufacturers can leverage additional growth opportunities by:
Offering sample preparation equipment, liquid chromatographs for compositional testing, and chromatography data system software for compliance management.Ensuring personalization and customization of solutions so they may address market needs instead of merely providing a product.Developing advanced techniques, including two-dimensional chromatograph systems.Presenting powerful software for biosimilars analysis to simplify human interpretation during analysis.Working with regulatory authorities to tighten the regulatory requirements for biosimilars in emerging countries.Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025 is part of Frost & Sullivan's global Test & Measurement Growth Partnership Service program.
About Frost & Sullivan
For over five decades, Frost & Sullivan has become world-renowned for its role in helping investors, corporate leaders and governments navigate economic changes and identify disruptive technologies, Mega Trends, new business models and companies to action, resulting in a continuous flow of growth opportunities to drive future success. Contact us: Start the discussion.
(Disclaimer--Features may vary depending on the regions; subject to change without notice.)
Global Analytical Instrumentation Market in Pharmaceuticals, Biopharmaceuticals, and Nutraceuticals, Forecast to 2025
K3BA-30
Contact:
Jaylon Brinkley
E: [email protected]
P: (210)247-2481
http://ww2.frost.com
Please log in to get detailed story.
Tags: #Drug Manufacturers Eye Analytical Instrumentation to Reduce Operating Costs
More News

Rupee ends flat at 83 32 against USD

25 Apr 2024 | 4:50 PM

Mumbai, April 25 (UNI) The rupee on Thursday ended steady at 83.32 against the USD on selling US dollars by bankers and exporters, dealers at the foreign exchange said.

see more..

Shree Cement joins RE100

25 Apr 2024 | 4:32 PM

Mumbai, Apr 25 (UNI) Shree Cement, one of India's largest cement producers with an installed capacity of over 56 MTPA, has announced its membership in the esteemed RE100 initiative, a global initiative led by Climate Group, advocating for businesses to convert to 100 per cent renewable electricity for all their operations.

see more..

Vedanta net down 27 pc in Q4

25 Apr 2024 | 4:26 PM

Mumbai, Apr 25 (UNI) Indian mining company Vedanta, with its operations in iron ore, aluminium, zinc, oil and gas, on Thursday reported 27 per cent dip in net profit at Rs 2,273 crore for the fourth quarter (January-March) of FY 24 from Rs 3,132 crore in same period a year ago.

see more..

India’s John Distilleries ‘Nirvana’ wins at London Spirits Competition

25 Apr 2024 | 3:25 PM

New Delhi, April 25 (UNI) John Distilleries Ltd’s Paul John single malt whiskey ‘Nirvana’ has been awarded a “Gold” medal in the prestigious London Spirits Competition 2024. JDL’s two other offerings, Roulette London Dry Gin and Paul John XO Brandy, have also won ‘Silver’ medals. JDL is the only Indian company to have been awarded in three different categories: whiskey, gin, and brandy.

see more..
Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

Dr Reddy’s Lab and Nestlé India enter into definitive agreement to form JV company

25 Apr 2024 | 2:40 PM

Hyderabad, April 25 (UNI) Dr. Reddy’s Laboratories and Nestlé India have entered into a definitive agreement to form a joint venture company to bring innovative nutraceutical brands to consumers in India and other agreed territories.

see more..
image